Sumerel LA - Search Results

1

The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells.

Kim M, Zinn KR, Barnett BG, Sumerel LA, Krasnykh V, Curiel DT, Douglas JT. Kim M, et al. Among authors: sumerel la. Eur J Cancer. 2002 Sep;38(14):1917-26. doi: 10.1016/s0959-8049(02)00131-4. Eur J Cancer. 2002. PMID: 12204675

2

Efficient oncolysis by a replicating adenovirus (ad) in vivo is critically dependent on tumor expression of primary ad receptors.

Douglas JT, Kim M, Sumerel LA, Carey DE, Curiel DT. Douglas JT, et al. Among authors: sumerel la. Cancer Res. 2001 Feb 1;61(3):813-7. Cancer Res. 2001. PMID: 11221860

3

The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells.

Kim M, Sumerel LA, Belousova N, Lyons GR, Carey DE, Krasnykh V, Douglas JT. Kim M, et al. Among authors: sumerel la. Br J Cancer. 2003 May 6;88(9):1411-6. doi: 10.1038/sj.bjc.6600932. Br J Cancer. 2003. PMID: 12778071 Free PMC article.

4

Tissue inhibitor of metalloproteinases-2 improves antitumor efficacy of a replicating adenovirus in vivo.

Kim MH, Bodenstine TM, Sumerel LA, Rivera AA, Baker AH, Douglas JT. Kim MH, et al. Among authors: sumerel la. Cancer Biol Ther. 2006 Dec;5(12):1647-53. doi: 10.4161/cbt.5.12.3374. Epub 2006 Dec 7. Cancer Biol Ther. 2006. PMID: 17106248 Free PMC article.

5

A Sindbis virus mRNA polynucleotide vector achieves prolonged and high level heterologous gene expression in vivo.

Johanning FW, Conry RM, LoBuglio AF, Wright M, Sumerel LA, Pike MJ, Curiel DT. Johanning FW, et al. Among authors: sumerel la. Nucleic Acids Res. 1995 May 11;23(9):1495-501. doi: 10.1093/nar/23.9.1495. Nucleic Acids Res. 1995. PMID: 7784202 Free PMC article.

6

Characterization of a messenger RNA polynucleotide vaccine vector.

Conry RM, LoBuglio AF, Wright M, Sumerel L, Pike MJ, Johanning F, Benjamin R, Lu D, Curiel DT. Conry RM, et al. Cancer Res. 1995 Apr 1;55(7):1397-400. Cancer Res. 1995. PMID: 7882341

7

A carcinoembryonic antigen polynucleotide vaccine for human clinical use.

Conry RM, LoBuglio AF, Loechel F, Moore SE, Sumerel LA, Barlow DL, Pike J, Curiel DT. Conry RM, et al. Among authors: sumerel la. Cancer Gene Ther. 1995 Mar;2(1):33-8. Cancer Gene Ther. 1995. PMID: 7621253 Clinical Trial.

8

A carcinoembryonic antigen polynucleotide vaccine has in vivo antitumor activity.

Conry RM, LoBuglio AF, Loechel F, Moore SE, Sumerel LA, Barlow DL, Curiel DT. Conry RM, et al. Among authors: sumerel la. Gene Ther. 1995 Jan;2(1):59-65. Gene Ther. 1995. PMID: 7712333

9

Immune response to a carcinoembryonic antigen polynucleotide vaccine.

Conry RM, LoBuglio AF, Kantor J, Schlom J, Loechel F, Moore SE, Sumerel LA, Barlow DL, Abrams S, Curiel DT. Conry RM, et al. Among authors: sumerel la. Cancer Res. 1994 Mar 1;54(5):1164-8. Cancer Res. 1994. PMID: 8118800

10

An animal model to predict the immunogenicity of murine V regions in humans.

Cartner AM, Conry RM, Safavy A, Khazaeli MB, Sumerel LA, LoBuglio AF. Cartner AM, et al. Among authors: sumerel la. Hum Antibodies Hybridomas. 1993 Oct;4(4):174-80. Hum Antibodies Hybridomas. 1993. PMID: 8257770

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters